Publication | Open Access
NDUFA4L2 Fine-tunes Oxidative Stress in Hepatocellular Carcinoma
86
Citations
37
References
2016
Year
Our study has provided the first clinical relevance of NDUFA4L2 in human cancer and suggested that HCC patients with NDUFA4L2 overexpression may be suitable candidates for HIF inhibitor treatment. Clin Cancer Res; 22(12); 3105-17. ©2016 AACR.
| Year | Citations | |
|---|---|---|
Page 1
Page 1